Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists

E. W. Inscho, P. K. Carmines, L. G. Navar

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The present study was designed to evaluate, at the microvascular level, the ability of prostaglandins E2 (PGE) and I2 (PGI2) to counteract the afferent vasoconstrictor effects of angiotensin II (ANG II) and norepinephrine (NE). The renal microvasculature of rats pretreated with captopril and indomethacin was studied directly by use of the in vitro blood-perfused juxtamedullary nephron technique combined with videomicroscopy. Afferent arterioles averaged 22-7 ± 0.6 μm ID (n = 59) under control conditions. Topical administration of PGE2 revealed a concentration-dependent afferent vasoconstriction, whereas PGI2 (10-7 to 10 -5 M) failed to significantly alter afferent arteriolar diameter. Afferent arterioles constricted during exposure to either 10-9 M ANG II (-15 ± 3%, n = 13) or 10-7 M NE (-19 ± 3%, n = 13). Addition of PGE2 (10-6 M) to the bathing solution enhanced the vasoconstrictor influences of ANG II and NE by an additional 18 ± 6 and 13 ± 4%, respectively. In contrast, while 10-6 M PGI2 had no effect on ANG II-induced afferent vasoconstriction, it did produce a 30% attenuation of NE-induced constriction. Furthermore, pretreatment of the tissue with 10-6 M PGI2 prevented development of NE-induced afferent vasoconstriction. Thus, although local tissue prostanoid concentrations are unknown, it appears that low micromolar concentrations of PGE2 elicit an afferent arteriolar constriction that can accentuate the vascular actions of ANG II and NE on rat juxtamedullary afferent arterioles. In contrast, PGI2 can counteract the vasoconstrictor response to NE, but not ANG II, in this experimental setting.

Original languageEnglish (US)
Pages (from-to)F157-F163
JournalAmerican Journal of Physiology - Renal Fluid and Electrolyte Physiology
Volume259
Issue number1 28-1
StatePublished - Jan 1 1990

Fingerprint

Vasoconstrictor Agents
Prostaglandins
Norepinephrine
Angiotensin II
Dinoprostone
Arterioles
Vasoconstriction
Prostaglandins E
Constriction
Topical Administration
Video Microscopy
Captopril
Nephrons
Epoprostenol
Microvessels
Indomethacin
Blood Vessels
Kidney

Keywords

  • Afferent arteriole
  • Angiotensin II
  • Juxtamedullary nephron
  • Norepinephrine
  • Prostaglandin E
  • Prostaglandin I
  • rat

ASJC Scopus subject areas

  • Physiology

Cite this

Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. / Inscho, E. W.; Carmines, P. K.; Navar, L. G.

In: American Journal of Physiology - Renal Fluid and Electrolyte Physiology, Vol. 259, No. 1 28-1, 01.01.1990, p. F157-F163.

Research output: Contribution to journalArticle

@article{a145c2fd9da744d792abe5a75f7304ba,
title = "Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists",
abstract = "The present study was designed to evaluate, at the microvascular level, the ability of prostaglandins E2 (PGE) and I2 (PGI2) to counteract the afferent vasoconstrictor effects of angiotensin II (ANG II) and norepinephrine (NE). The renal microvasculature of rats pretreated with captopril and indomethacin was studied directly by use of the in vitro blood-perfused juxtamedullary nephron technique combined with videomicroscopy. Afferent arterioles averaged 22-7 ± 0.6 μm ID (n = 59) under control conditions. Topical administration of PGE2 revealed a concentration-dependent afferent vasoconstriction, whereas PGI2 (10-7 to 10 -5 M) failed to significantly alter afferent arteriolar diameter. Afferent arterioles constricted during exposure to either 10-9 M ANG II (-15 ± 3{\%}, n = 13) or 10-7 M NE (-19 ± 3{\%}, n = 13). Addition of PGE2 (10-6 M) to the bathing solution enhanced the vasoconstrictor influences of ANG II and NE by an additional 18 ± 6 and 13 ± 4{\%}, respectively. In contrast, while 10-6 M PGI2 had no effect on ANG II-induced afferent vasoconstriction, it did produce a 30{\%} attenuation of NE-induced constriction. Furthermore, pretreatment of the tissue with 10-6 M PGI2 prevented development of NE-induced afferent vasoconstriction. Thus, although local tissue prostanoid concentrations are unknown, it appears that low micromolar concentrations of PGE2 elicit an afferent arteriolar constriction that can accentuate the vascular actions of ANG II and NE on rat juxtamedullary afferent arterioles. In contrast, PGI2 can counteract the vasoconstrictor response to NE, but not ANG II, in this experimental setting.",
keywords = "Afferent arteriole, Angiotensin II, Juxtamedullary nephron, Norepinephrine, Prostaglandin E, Prostaglandin I, rat",
author = "Inscho, {E. W.} and Carmines, {P. K.} and Navar, {L. G.}",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "259",
pages = "F157--F163",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1 28-1",

}

TY - JOUR

T1 - Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists

AU - Inscho, E. W.

AU - Carmines, P. K.

AU - Navar, L. G.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The present study was designed to evaluate, at the microvascular level, the ability of prostaglandins E2 (PGE) and I2 (PGI2) to counteract the afferent vasoconstrictor effects of angiotensin II (ANG II) and norepinephrine (NE). The renal microvasculature of rats pretreated with captopril and indomethacin was studied directly by use of the in vitro blood-perfused juxtamedullary nephron technique combined with videomicroscopy. Afferent arterioles averaged 22-7 ± 0.6 μm ID (n = 59) under control conditions. Topical administration of PGE2 revealed a concentration-dependent afferent vasoconstriction, whereas PGI2 (10-7 to 10 -5 M) failed to significantly alter afferent arteriolar diameter. Afferent arterioles constricted during exposure to either 10-9 M ANG II (-15 ± 3%, n = 13) or 10-7 M NE (-19 ± 3%, n = 13). Addition of PGE2 (10-6 M) to the bathing solution enhanced the vasoconstrictor influences of ANG II and NE by an additional 18 ± 6 and 13 ± 4%, respectively. In contrast, while 10-6 M PGI2 had no effect on ANG II-induced afferent vasoconstriction, it did produce a 30% attenuation of NE-induced constriction. Furthermore, pretreatment of the tissue with 10-6 M PGI2 prevented development of NE-induced afferent vasoconstriction. Thus, although local tissue prostanoid concentrations are unknown, it appears that low micromolar concentrations of PGE2 elicit an afferent arteriolar constriction that can accentuate the vascular actions of ANG II and NE on rat juxtamedullary afferent arterioles. In contrast, PGI2 can counteract the vasoconstrictor response to NE, but not ANG II, in this experimental setting.

AB - The present study was designed to evaluate, at the microvascular level, the ability of prostaglandins E2 (PGE) and I2 (PGI2) to counteract the afferent vasoconstrictor effects of angiotensin II (ANG II) and norepinephrine (NE). The renal microvasculature of rats pretreated with captopril and indomethacin was studied directly by use of the in vitro blood-perfused juxtamedullary nephron technique combined with videomicroscopy. Afferent arterioles averaged 22-7 ± 0.6 μm ID (n = 59) under control conditions. Topical administration of PGE2 revealed a concentration-dependent afferent vasoconstriction, whereas PGI2 (10-7 to 10 -5 M) failed to significantly alter afferent arteriolar diameter. Afferent arterioles constricted during exposure to either 10-9 M ANG II (-15 ± 3%, n = 13) or 10-7 M NE (-19 ± 3%, n = 13). Addition of PGE2 (10-6 M) to the bathing solution enhanced the vasoconstrictor influences of ANG II and NE by an additional 18 ± 6 and 13 ± 4%, respectively. In contrast, while 10-6 M PGI2 had no effect on ANG II-induced afferent vasoconstriction, it did produce a 30% attenuation of NE-induced constriction. Furthermore, pretreatment of the tissue with 10-6 M PGI2 prevented development of NE-induced afferent vasoconstriction. Thus, although local tissue prostanoid concentrations are unknown, it appears that low micromolar concentrations of PGE2 elicit an afferent arteriolar constriction that can accentuate the vascular actions of ANG II and NE on rat juxtamedullary afferent arterioles. In contrast, PGI2 can counteract the vasoconstrictor response to NE, but not ANG II, in this experimental setting.

KW - Afferent arteriole

KW - Angiotensin II

KW - Juxtamedullary nephron

KW - Norepinephrine

KW - Prostaglandin E

KW - Prostaglandin I

KW - rat

UR - http://www.scopus.com/inward/record.url?scp=0025100397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025100397&partnerID=8YFLogxK

M3 - Article

C2 - 2115739

AN - SCOPUS:0025100397

VL - 259

SP - F157-F163

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1 28-1

ER -